IDEXX Laboratories Inc (IDXX)
489.28
-4.98
(-1.01%)
USD |
NASDAQ |
Apr 25, 16:00
489.28
0.00 (0.00%)
After-Hours: 20:00
IDEXX Laboratories Research and Development Expense (Quarterly): 51.81M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 51.81M |
| September 30, 2023 | 47.97M |
| June 30, 2023 | 46.50M |
| March 31, 2023 | 44.67M |
| December 31, 2022 | 43.42M |
| September 30, 2022 | 48.01M |
| June 30, 2022 | 123.22M |
| March 31, 2022 | 40.17M |
| December 31, 2021 | 45.31M |
| September 30, 2021 | 40.43M |
| June 30, 2021 | 37.70M |
| March 31, 2021 | 37.58M |
| December 31, 2020 | 38.78M |
| September 30, 2020 | 37.52M |
| June 30, 2020 | 31.64M |
| March 31, 2020 | 33.31M |
| December 31, 2019 | 35.16M |
| September 30, 2019 | 34.26M |
| June 30, 2019 | 32.26M |
| March 31, 2019 | 31.51M |
| December 31, 2018 | 30.14M |
| September 30, 2018 | 29.19M |
| June 30, 2018 | 29.51M |
| March 31, 2018 | 29.02M |
| December 31, 2017 | 28.81M |
| Date | Value |
|---|---|
| September 30, 2017 | 27.58M |
| June 30, 2017 | 27.00M |
| March 31, 2017 | 25.79M |
| December 31, 2016 | 25.42M |
| September 30, 2016 | 25.67M |
| June 30, 2016 | 25.41M |
| March 31, 2016 | 24.62M |
| December 31, 2015 | 25.50M |
| September 30, 2015 | 24.86M |
| June 30, 2015 | 24.32M |
| March 31, 2015 | 25.01M |
| December 31, 2014 | 24.87M |
| September 30, 2014 | 24.85M |
| June 30, 2014 | 25.43M |
| March 31, 2014 | 23.11M |
| December 31, 2013 | 22.50M |
| September 30, 2013 | 21.57M |
| June 30, 2013 | 22.18M |
| March 31, 2013 | 21.76M |
| December 31, 2012 | 21.05M |
| September 30, 2012 | 20.35M |
| June 30, 2012 | 20.06M |
| March 31, 2012 | 20.56M |
| December 31, 2011 | 20.20M |
| September 30, 2011 | 19.41M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
31.64M
Minimum
Jun 2020
123.22M
Maximum
Jun 2022
44.72M
Average
40.17M
Median
Mar 2022
Research and Development Expense (Quarterly) Benchmarks
| Stryker Corp | 350.00M |
| Haemonetics Corp | 13.26M |
| Align Technology Inc | 82.16M |
| Edwards Lifesciences Corp | 270.00M |
| ACADIA Pharmaceuticals Inc | 66.74M |